Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.

about

Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.

Item

http://www.wikidata.org/entity/Q51769247

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Homozygous Familial Hyperchole ...... or the Efficacy of Evolocumab.

@en

Homozygous Familial Hyperchole ...... ions Variably Express the LDLR

@nl

type

Item

label

Homozygous Familial Hyperchole ...... or the Efficacy of Evolocumab.

@en

Homozygous Familial Hyperchole ...... ions Variably Express the LDLR

@nl

prefLabel

Homozygous Familial Hyperchole ...... or the Efficacy of Evolocumab.

@en

Homozygous Familial Hyperchole ...... ions Variably Express the LDLR

@nl

P1476

Homozygous Familial Hyperchole ...... or the Efficacy of Evolocumab.

@en

P2093

Aurélie Thedrez

http://www.w3.org/2001/XMLSchema#string

Bertrand Cariou

http://www.w3.org/2001/XMLSchema#string

Dirk J Blom

http://www.w3.org/2001/XMLSchema#string

Frederick J Raal

http://www.w3.org/2001/XMLSchema#string

Kévin Chemello

http://www.w3.org/2001/XMLSchema#string

Lihua Tang

http://www.w3.org/2001/XMLSchema#string

Michel Farnier

http://www.w3.org/2001/XMLSchema#string

Mikaël Croyal

http://www.w3.org/2001/XMLSchema#string

Stéphane Ramin-Mangata

http://www.w3.org/2001/XMLSchema#string

P2860

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders

Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Vitamin B12 insufficiency induces cholesterol biosynthesis by limiting s-adenosylmethionine and modulating the methylation of SREBF1 and LDLR genes.

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.

Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia.

Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.

Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.

Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.

P304

592-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.117.310217

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29284604

http://www.w3.org/2001/XMLSchema#string

P921

homozygous familial hypercholesterolemia

hypercholesterolemia

P932

5823753

http://www.w3.org/2001/XMLSchema#string